Artificial Vital Organs And Medical Bionics Market Size, Share & Trends Analysis Report By Artificial Organs (Heart, Kidney, Liver), By Bionics (Ear Bionics, Vision Bionics, Exoskeletons), By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2025-2034

Artificial Vital Organs And Medical Bionics Market Size and Trends

The artificial vital organs and medical bionics market size was exhibited at USD 41.13 billion in 2024 and is projected to hit around USD 101.01 billion by 2034, growing at a CAGR of 9.4% during the forecast period 2025 to 2034.

Artificial Vital Organs And Medical Bionics Market Key Takeaways:

• The heart segment dominated the market with a revenue share of 57.3% in 2024.
• The pancreas segment is expected to experience the fastest growth with a CAGR of 10.4% over the forecast period.
• Brain bionics dominated the artificial vital organs and medical bionics market with a revenue share of 35.0% in 2024.
• Exoskeleton bionics are expected to register the fastest growth over the forecast period with a CAGR of 10.6%.
• North America artificial vital organs and medical bionics market dominated the global artificial vital organs and medical bionics market with a revenue share of 45.0% in 2024.

U.S. Artificial Vital Organs and Medical Bionics Market Size and Growth 2025 to 2034

The U.S. artificial vital organs and medical bionics market size is evaluated at USD 13.9 billion in 2024 and is projected to be worth around USD 34.1 billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034.

North America artificial vital organs and medical bionics market dominated the global artificial vital organs and medical bionics market with a revenue share of 45.0% in 2024. This growth can be attributed to different factors together with technological development, an increase in investment in research and development, positive assistance from the government, and an upward push in the variety of patients who are geared up for analysis.

U.S. Artificial Vital Organs And Medical Bionics Market Trends

U.S. artificial vital organs and medical bionics market dominated the North America artificial vital organs and medical bionics market with a revenue share of 71.8% in 2024 and is expected to grow during the forecast period due to well-established healthcare infrastructure and high demand for advanced medical technologies such as artificial vital organs and medical bionics.

Europe Artificial Vital Organs And Medical Bionics Market Trends

Europe artificial vital organs and medical bionics market was identified as a lucrative region in this industry. Increasing awareness regarding healthcare, enhancement of healthcare infrastructure, and rapid technological advancements are some of the factors driving market growth. In addition, there is an increase in the adoption of artificial organs, high levels of technologies, and better healthcare infrastructure is likely to drive the market growth.

The UK artificial vital organs and medical bionics market has a significant market share. The shortage of organ donors and the high demand for artificial vital organs driving the growth of the market. There is a growing fashion inside the UK towards implantable medical bionics, which offers extra permanent answers as compared to external gadgets.

The artificial vital organs and medical bionics market in Germany is expected to grow in the forecast period due to the rising prevalence of chronic diseases that require organ replacement and bionic implants. With the increase in the geriatric population, the rise in chronic diseases is a common result of an increase in market growth.

Asia Pacific Artificial Vital Organs And Medical Bionics Market Trends

Asia Pacific artificial vital organs and medical bionics market is expected to the fastest growth in the forecast period with a CAGR of 11.1%. Due to rising disposable income, elevated healthcare infrastructure, and awareness the marketplace is displaying growth within the forecast period. Countries inside the Asia Pacific place have an excessive population base with a massive amount of people with continual diseases that may pressure the marketplace boom.

China artificial vital organs and medical bionics market is expected to grow in the forecast period due to a rise in chronic diseases that lead to organ failure and an increase in the geriatric population driving the market growth. Due to rapid urbanization, people tend towards unhealthy diets and consumption of alcohol which result in organ failure and drive the growth of the market.

The artificial vital organs and medical bionics market in India is expected to have significant growth in the forecast period. This growth can be attributed to the rise in the geriatric population, increase in the road accidents, and enhancement in the technology.

Report Scope of Artificial Vital Organs And Medical Bionics Market

Artificial Vital Organs And Medical Bionics Market By Artificial Organ Insights

The heart segment dominated the market with a revenue share of 57.3% in 2024. This increase is happening due to an increase in the incidence of chronic diseases, scarcity of hearts for transplant, and advancement of the operations and potent effective drugs and treatment. Advanced transplant of artificial parts, and bionics equipment such as artificial hearts, livers, eyes, etc. due to their better biological compatibility, safety, and life span turn the life of a patient into a better one.

The pancreas segment is expected to experience the fastest growth with a CAGR of 10.4% over the forecast period. The primary driver for this is an increase in the number of diabetic patients. Furthermore, Advancements in technology, enhancement in surgical procedures, and impressive success rates of surgeries are the reasons behind the market expansion of pancreas transplants in the forecast period. Pancreas transplantation patients are enduring improved results and quality of life. Better survival outcomes and other long-term impacts of pancreas transplants have contributed to the patient’s awareness of the benefits of the procedure.

Artificial Vital Organs And Medical Bionics Market By Bionic Insights

Brain bionics dominated the artificial vital organs and medical bionics market with a revenue share of 35.0% in 2024. Increased prevalence of neurological conditions such as Parkinson’s disease, depression, and epilepsy are driving market growth. Moreover, advancements in technology regarding neural implants, neuroprosthetics, and improvements in treatments help patients with new hope and quality of life with this more patients are getting diagnosed with the treatment.

Exoskeleton bionics are expected to register the fastest growth over the forecast period with a CAGR of 10.6%. Exoskeletons are more often applied in the context of rehabilitation from strokes, spinal cord injuries, or other neurological disorders enhancing movement and motor skills. Moreover, the rapidly aging population is also increasing the demand for exoskeletons since individuals in their old age require assistance in moving around. Apart from healthcare, exoskeleton technology is being used in construction, logistics, and manufacturing to avoid work-related accidents and to increase worker performance. The cases of spinal cord injuries that cause paralysis further boost the bionic exoskeleton market as they result in permanent disabilities.

Some of the prominent players in the artificial vital organs and medical bionics market include:

• Medtronic, Inc.
• LifeNet Health
• Terumo Corporation
• Ekso Bionics Holdings, Inc.
• Nano Retina Ltd.
• Edwards Lifesciences Corporation
• InnoScot Health Ltd.
• Ottobock SE & Co. KGaA
• Orthofix Medical Inc.

Artificial Vital Organs And Medical Bionics Market Recent Developments

• In January 2024, EKSO Bionics introduced GaitCoach, a gait therapy software. The software was designed to enhance the patient experience with exoskeletons, aiming to increase user confidence and provide meaningful feedback.
  
  
• In April 2024, Medtronic announced the launch of Mozarc Medical, an unbiased agency committed to reshaping the fitness of kidney fitness and riding affected person-focused technological innovation.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the artificial vital organs and medical bionics market

By Artificial Organs

• Heart
• Kidney
• Liver
• Pancreas
• Lungs

By Bionics

• Ear Bionics
• Vision Bionics
• Exoskeletons
• Bionic Limbs
• Brain Bionics
• Cardiac Bionics

By Regional

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)